Uncovering a Potential Biomarker for Myasthenia Gravis
Developments in DMD Treatment: The First Nonsteroidal Drug Approval
The CLL Landscape: A Look at Current and Future Therapies
Navigating CLL Treatment: A Deep Dive into Efficacy and Safety
Managing Refractory Cytomegalovirus After Hematopoietic Cell Transplant
Understanding the Key Role of FcRn in Anti-AChR Antibody Positive gMG
Nicholas J. Silvestri, MD, FAAN
PeerExamining 2 Treatment Options for Anti-AChR Antibody Positive gMG: An Overview of the Trial Designs
Charulatha P. Nagar, MD
PeerTreating Anti-AChR Antibody Positive gMG: Clinical Trials for 2 Treatment Options
Tuan H. Vu, MD
PeerUnderstanding the Dosing and Administration of 2 Treatment Options for Anti-AChR Antibody Positive gMG
Jennifer Buczyner, MD
PeerUnderstanding Individualized Treatment Goals for gMG
Beth Stein, MD
Peer